France's 2026 VAT & Import Rules for Non-EU Medical Devices

France's 2026 VAT & Import Rules: A Guide for Non-EU Medical Device Manufacturers ===================================================================================== For non-EU medical device manufacturers, navigating the complexities of the European market has long been dominated by the regulatory requirements of the CE marking process under the EU Medical Device Regulation (MDR). However, significant changes to France's Value-Added Tax (VAT) and import requirements, set to begin implementation in 2026, are introducing a critical new layer of compliance. These fiscal regulations, while seemingly separate from regulatory affairs, have the potential to severely disrupt supply chains, halt imports, and create significant non-compliance risks for manufacturers who are not prepared. These upcoming reforms require non-EU companies importing and selling devices in France to adapt their logistical and financial operations. A key change involves the need to appoint a local fiscal representative to manage VAT obligations. This creates a clear distinction between the responsibilities of an EU Authorized Representative (AR), who manages regulatory compliance under the MDR, and a VAT Fiscal Representative, who manages tax compliance. Understanding the unique duties of each role is essential for ensuring seamless and uninterrupted market access. Failure to address these new fiscal requirements could lead to goods being stopped at the border, jeopardizing relationships with distributors and access to patients. This guide provides a detailed overview of the changes and outlines actionable steps for non-EU medical device manufacturers to ensure they remain compliant. ### Key Points * **Mandatory E-Invoicing and VAT Reform:** Beginning in 2026, France is rolling out a major reform that mandates business-to-business (B2B) electronic invoicing and digital reporting of VAT data. This affects all companies, including non-EU entities, selling goods in France. * **Fiscal Representative is Often Required:** Non-EU medical device manufacturers importing goods directly into France will generally be required to appoint a French VAT Fiscal Representative to manage their tax obligations, including VAT registration, filing, and payment. * **Distinct Roles of AR and Fiscal Rep:** The EU Authorized Representative (mandated by the MDR for regulatory compliance) and the VAT Fiscal Representative (mandated by tax law for fiscal compliance) are separate, non-interchangeable roles. Both may be necessary for compliant market access. * **Major Supply Chain Implications:** Non-compliance with the new import and VAT rules can result in significant shipment delays, customs holds, and an inability to clear products into the EU through France, directly impacting revenue and distributor relationships. * **QMS and Procedural Updates are Necessary:** Manufacturers must update their Quality Management System (QMS), particularly procedures related to importation, distribution, and supplier management, to incorporate the new role and responsibilities of the French fiscal representative. * **Proactive Strategy is Essential:** Companies currently using France as their primary EU entry point should immediately evaluate their strategy. This includes vetting and appointing a fiscal representative or considering alternative EU importation routes well in advance of the 2026 deadline. ## Understanding France's 2026 VAT and E-Invoicing Reforms The French government is implementing a comprehensive reform aimed at modernizing VAT collection, reducing tax fraud, and simplifying reporting. The core components of this reform, which start taking effect in 2026, are: 1. **Mandatory Electronic Invoicing (E-invoicing):** For all domestic B2B transactions, companies will be required to issue and receive invoices in a structured electronic format through a government-certified platform. Traditional PDF invoices sent via email will no longer be compliant for these transactions. 2. **Electronic Reporting (E-reporting):** Data for other transactions, such as business-to-consumer (B2C) sales and international B2B sales (including imports), must be electronically transmitted to the French tax authorities (DGFiP). For a non-EU medical device manufacturer, this means that the entire process of importing goods into France and selling them to French distributors or hospitals will fall under these new digital requirements. The practical consequence is that any non-EU company acting as the importer of record will need a French VAT number and a mechanism to comply with these e-invoicing and e-reporting rules. In most cases, this necessitates appointing a local expert—a VAT Fiscal Representative. ## EU Authorized Representative vs. VAT Fiscal Representative: A Critical Distinction A common point of confusion for manufacturers is the difference between the EU Authorized Representative (AR) and the VAT Fiscal Representative. While both are mandatory third parties for non-EU companies under certain conditions, their roles, responsibilities, and legal bases are entirely separate. A manufacturer’s AR cannot typically act as their fiscal representative. | Feature | EU Authorized Representative (AR) | VAT Fiscal Representative | | :--- | :--- | :--- | | **Legal Basis** | Regulation (EU) 2017/745 (MDR) & 2017/746 (IVDR) | French Tax Code & EU VAT Directive | | **Primary Focus** | **Regulatory Compliance:** Device safety and performance. | **Fiscal Compliance:** VAT registration, filing, and payment. | | **Key Responsibilities** | - Verify DoC and technical documentation. <br>- Act as the primary contact for EU Competent Authorities. <br>- Be identified on device labeling, packaging, and instructions. <br>- Handle post-market surveillance and vigilance reporting duties. <br>- Keep documentation available for inspection. | - Register the non-EU company for a French VAT number. <br>- Prepare and submit periodic VAT returns. <br>- Manage VAT payments and refunds. <br>- Liaise with French tax authorities (DGFiP). <br>- Ensure compliance with e-invoicing and e-reporting rules. | | **Liability** | Jointly and severally liable with the manufacturer for defective devices. | Jointly and severally liable for the manufacturer's VAT debts in France. | Attempting to use one entity for both roles is not feasible and creates significant compliance gaps. A non-EU manufacturer must ensure they have appointed the correct party for each distinct function. ## Impact on Supply Chain and QMS The 2026 French VAT reforms are not just a financial issue; they are a core logistical challenge that directly impacts the supply chain and requires formal integration into a company's QMS. ### Logistics and Customs Clearance When a medical device shipment from a non-EU country arrives at a French port or airport (e.g., Charles de Gaulle Airport, Port of Le Havre), the importer of record must handle the customs clearance process. This includes paying import duties and VAT. Without a valid French VAT number and a compliant process for managing import VAT, shipments can be: * **Delayed or Held by Customs:** French customs authorities will not release goods if the import documentation is incorrect or the importer cannot demonstrate compliance with VAT regulations. * **Refused Entry:** In severe cases of non-compliance, shipments may be refused entry and forced to be returned to the country of origin at the manufacturer's expense. * **Disrupted Distributor Relationships:** Chronic delays prevent products from reaching distributors and end-users (hospitals, clinics), damaging business relationships and the manufacturer's reputation for reliability. ### Required QMS Updates To ensure continued compliance, manufacturers must review and update their QMS procedures. Key areas include: * **Supplier and Partner Management:** Procedures for qualifying and managing critical partners must be updated to include the VAT Fiscal Representative. This involves establishing a formal contract or letter of appointment that clearly defines roles and responsibilities. * **Importation and Distribution Procedures:** Standard Operating Procedures (SOPs) for shipping and importation must be revised to reflect the new requirements. This includes instructions on how to correctly declare the importer of record, use the correct VAT number, and manage documentation for customs brokers. * **Record Keeping:** QMS record-keeping policies must be expanded to include all VAT-related documentation, such as fiscal representation agreements, VAT returns, and correspondence with tax authorities. ## Scenarios: Evaluating Your EU Importation Strategy The impact of these changes will vary depending on a manufacturer's current logistics setup. ### Scenario 1: Manufacturer Using France as its Primary EU Entry Point * **Situation:** A U.S.-based SaMD company ships its physical hardware components to a third-party logistics (3PL) provider in Lyon, France. From there, the goods are distributed throughout the EU. The U.S. company has been acting as the importer of record. * **Immediate Challenges:** Starting in 2026, this company will be unable to act as the importer without a French VAT registration and a compliant e-invoicing process. Their current 3PL provider may not offer fiscal representation services. * **Actionable Steps:** 1. **Vet and Appoint:** The company must immediately begin the process of finding and appointing a qualified French VAT Fiscal Representative. 2. **Revise Contracts:** They need to review their contract with the 3PL provider to clarify roles and ensure all parties understand the new import process. 3. **Update SOPs:** Internal shipping and logistics SOPs must be updated with the new VAT number and instructions for their freight forwarder. 4. **Budget Accordingly:** The cost of fiscal representation services must be incorporated into their EU operational budget. ### Scenario 2: Manufacturer Using a Non-French EU Entry Point (e.g., Netherlands) * **Situation:** A Canadian orthopedic implant manufacturer imports all its EU products through Rotterdam, Netherlands. The goods clear customs there, enter free circulation within the EU, and are then shipped to various customers, including a large distributor in France. * **Challenges:** While direct importation into France is not an issue, their sales *to* the French distributor are still subject to French VAT rules. The new e-invoicing mandate applies to domestic B2B transactions, and cross-border sales will have e-reporting requirements. * **Actionable Steps:** 1. **Assess VAT Obligations:** The company must work with a tax advisor to understand its precise VAT obligations for intra-community sales into France. They may still need to register for French VAT. 2. **Evaluate Invoicing Systems:** They need to ensure their invoicing system can generate the compliant e-invoices required for their French customer. 3. **Strategic Review:** This is an opportune moment to confirm that their pan-EU distribution model remains efficient under the evolving VAT landscape across the EU (including the proposed "VAT in the Digital Age" or ViDA package). ## Strategic Considerations and Proactive Planning The 2026 deadline is approaching quickly. Manufacturers should take immediate steps to prepare. * **Act Now, Not in 2025:** Vetting, contracting, and onboarding a fiscal representative, along with updating internal systems and procedures, can take several months. Waiting until the last minute will likely lead to supply chain disruptions. * **Adopt a Holistic Compliance View:** EU market access is not just about the CE mark. Success depends on a unified strategy that integrates regulatory (MDR/IVDR), quality (QMS), and fiscal (VAT) compliance. A failure in one area can undermine the others. * **Re-evaluate Your EU Gateway:** Use this regulatory shift as an opportunity to conduct a strategic review of your EU importation and distribution strategy. Analyze whether France remains the optimal entry point or if another Member State (e.g., the Netherlands, Belgium, Germany) offers a more stable and predictable fiscal environment for your business model. * **Engage Qualified Experts:** Navigating international tax law is complex. Non-EU manufacturers should engage qualified tax advisors and fiscal representative providers who have specific experience with the medical device industry and a deep understanding of the upcoming French reforms. ## Finding and Comparing VAT Fiscal Representative Providers Choosing the right VAT Fiscal Representative is a critical decision. This partner will be jointly liable for your VAT obligations and will be a key link in your supply chain. When evaluating providers, consider the following: * **Experience with Medical Devices:** A provider who understands the medical device industry can better navigate specific challenges related to importation, classification, and sales to healthcare entities. * **Expertise in French Tax Law:** Ensure the provider has a proven track record and deep expertise specifically with the French tax authority (DGFiP) and the upcoming e-invoicing reforms. * **Clear Communication and Reporting:** The provider should offer clear, timely communication and transparent reporting on all filings and payments made on your behalf. * **Technology and Systems:** Inquire about the platform they use to manage e-invoicing and e-reporting to ensure it integrates smoothly with your own systems. Finding a qualified and vetted partner is crucial for a smooth transition. A specialized directory can help you connect with providers who meet these criteria. > **To find qualified vetted providers [click here](https://cruxi.ai/regulatory-directories/vat_fiscal_rep) and request quotes for free.** ## Key References When seeking further information, manufacturers should consult official sources. Be aware that timelines and technical details can be updated. * Official communications from the French Directorate General of Public Finances (DGFiP) regarding e-invoicing and VAT reform. * The EU VAT Directive (Council Directive 2006/112/EC), which provides the framework for VAT rules across the European Union. * Regulation (EU) 2017/745 on medical devices (MDR), for clarifying the distinct regulatory duties of the EU Authorized Representative. *** This article is for general educational purposes only and is not legal, medical, fiscal, or regulatory advice. For company-specific questions, sponsors should consult qualified experts. --- *This answer was AI-assisted and reviewed for accuracy by Lo H. Khamis.*